Paper3300530
Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy.
Pangon B and 7 others. Antimicrob Agents Chemother, 1987. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy. Papers, record 3300530. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3300530
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cefotaxime | Major topic |
| Ceftriaxone | Major topic |
| Endocarditis, Bacterial | Major topic |
| Escherichia coli | Major topic |
| Escherichia coli Infections | Major topic |
| Animals | |
| Cefmenoxime | |
| Cefotiam | |
| Drug Evaluation, Preclinical | |
| Kinetics | |
| Rabbits |
Source PubMed
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4492776 | Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci. | J Clin Invest | 1974 | https://conductscience.org/library/papers/4492776 | PubMed |
| 2 | 3710965 | Novel approaches for the use of aminoglycosides: the value of experimental models. | J Antimicrob Chemother | 1986 | https://conductscience.org/library/papers/3710965 | PubMed |
| 3 | 1086635 | New method for detecting in vitro inactivation of penicillins by Haemophilus influenzae and Staphlycoccus aureus. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/1086635 | PubMed |
| 4 | 6260870 | Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis. | J Infect Dis | 1981 | https://conductscience.org/library/papers/6260870 | PubMed |
| 5 | 7013003 | Continuous vs. intermittent administration of antimicrobial agents: tissue penetration and efficacy in vivo. | Rev Infect Dis | 1981 | https://conductscience.org/library/papers/7013003 | PubMed |
| 6 | 7033400 | Correlation of serum bactericidal activity with antimicrobial agent level and minimal bactericidal concentration. | J Infect Dis | 1982 | https://conductscience.org/library/papers/7033400 | PubMed |
| 7 | 6275779 | Pharmacokinetics of ceftriaxone in humans. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6275779 | PubMed |
| 8 | 6282203 | Intramuscular and intravenous pharmacokinetics of cefmenoxime, a new broad-spectrum cephalosporin, in healthy subjects. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6282203 | PubMed |
| 9 | 6297387 | Pharmacokinetics of cefotiam in normal humans. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6297387 | PubMed |
| 10 | 6826714 | Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits. | J Clin Invest | 1983 | https://conductscience.org/library/papers/6826714 | PubMed |
| 11 | 6316841 | Correlation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6316841 | PubMed |
| 12 | 3878128 | Influence of four modes of administration on penetration of aztreonam, cefuroxime, and ampicillin into interstitial fluid and fibrin clots and on in vivo efficacy against Haemophilus influenzae. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/3878128 | PubMed |
| 13 | 3510263 | Antibiotic therapy of infections due to Pseudomonas aeruginosa in normal and granulocytopenic mice: comparison of murine and human pharmacokinetics. | J Infect Dis | 1986 | https://conductscience.org/library/papers/3510263 | PubMed |
| 14 | 4091526 | Comparison of penicillin and vancomycin, individually and in combination with gentamicin and amikacin, in the treatment of experimental endocarditis induced by nutritionally variant streptococci. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/4091526 | PubMed |
| 15 | 3516963 | Kinetics and bactericidal effect of gentamicin and latamoxef (moxalactam) in experimental Escherichia coli endocarditis. | J Antimicrob Chemother | 1986 | https://conductscience.org/library/papers/3516963 | PubMed |
| 16 | 1117194 | Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus. | J Infect Dis | 1975 | https://conductscience.org/library/papers/1117194 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35056123 | FDA-Approved Oximes and Their Significance in Medicinal Chemistry. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/35056123 | PubMed |
| 11302801 | In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model. | Antimicrob Agents Chemother | 2001 | https://conductscience.org/library/papers/11302801 | PubMed |
| 7695248 | Parenteral sparfloxacin compared with ceftriaxone in treatment of experimental endocarditis due to penicillin-susceptible and -resistant streptococci. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/7695248 | PubMed |
| 3324957 | Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3324957 | PubMed |
| 3293977 | Cefotaxime optimal dosage in adult patients. A reappraisal. | Drugs | 1988 | https://conductscience.org/library/papers/3293977 | PubMed |
| 3282748 | Pulse dosing versus continuous infusion of antibiotics. Pharmacokinetic-pharmacodynamic considerations. | Clin Pharmacokinet | 1988 | https://conductscience.org/library/papers/3282748 | PubMed |
| 3048974 | Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration. | Drugs | 1988 | https://conductscience.org/library/papers/3048974 | PubMed |
| 2665645 | Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2665645 | PubMed |
| 2226482 | Significance of tissue levels for prediction of antibiotic efficacy and determination of dosage. | Eur J Clin Microbiol Infect Dis | 1990 | https://conductscience.org/library/papers/2226482 | PubMed |
| 2188586 | Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2188586 | PubMed |
| 2073099 | Ceftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamase. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2073099 | PubMed |
| 2069381 | Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/2069381 | PubMed |
| 1759831 | Single daily dosing of antibiotics: importance of in vitro killing rate, serum half-life, and protein binding. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/1759831 | PubMed |
| 1329634 | Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant. | Antimicrob Agents Chemother | 1992 | https://conductscience.org/library/papers/1329634 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3300530
GET https://conductscience.org/api/papers/v1/3300530/authors